Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

1602606

registered interest
date	08/03/2023
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Voluntary Scheme for Branded Medicines Pricing and Access
house id	2
legislature	25277 pref label House of Lords
question text	To ask His Majesty's Government what assessment they have made of the findings of the report by The Association of the British Pharmaceutical Industry False economy? How NHS medicine procurement threatens the UK’s Life Sciences growth engine, published on 23 February, that the continued current high rebate rates under the voluntary and statutory schemes for branded medicines during the next five years would mean foregoing £50 billion in GDP and £17.9 billion in tax revenues as a result of lost research and development investment; and what are their estimates of the value of the potential lost investment in this sector.
tabling member printed	Lord Warner
uin	HL6287
answer	answer is ministerial correction date of answer 23/03/2023 answer text <p>The Department carefully considers all evidence in the public domain on matters relating to the growth and competitiveness of the United Kingdom’s life science sector, including the recent report by the Association of the British Pharmaceutical Industry. This occurs in combination with broad engagement with individual companies, the National Health Service and with charities and patient representatives and will continue moving forward as part of the delivery of the Government’s Life Science Vision.</p> answering member printed Lord Markham grouped question UIN HL6285 question first answered 23/03/2023 11:34:32 answering member 4948 label Biography information for Lord Markham
tabling member	1732 label Biography information for Lord Warner

1433433

registered interest
date	21/02/2022
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Tixagevimab/cilgavimab
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty's Government how much Evusheld monoclonal antibody treatment they have secured; and when this treatment will be available to the clinically vulnerable in the UK.
tabling member printed	Lord Mendelsohn
uin	HL6287
answer	answer is ministerial correction date of answer 28/02/2022 answer text <p>Evusheld is not currently authorised for use in the United Kingdom. We continue to monitor a range of products, including Evusheld. However, we are unable to provide information on negotiations with companies as this is commercially sensitive.</p><p>On 5 October 2021, the Department invited suppliers to submit an expression of interest on neutralising antibody treatments being developed for treating and preventing COVID-19. This will enable the Department to undertake fair and transparent market engagement with suppliers.</p> answering member printed Lord Kamall question first answered 28/02/2022 17:26:48 answering member 4909 label Biography information for Lord Kamall
tabling member	4286 label Biography information for Lord Mendelsohn

1219479

registered interest
date	30/06/2020
answering body	Department for Business, Energy and Industrial Strategy
answering dept id	201
answering dept short name	Business, Energy and Industrial Strategy
answering dept sort name	Business, Energy and Industrial Strategy
hansard heading	Energy Performance Certificates
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty's Government, further to the conclusion of the report by the Committee on Climate Change Reducing UK emissions: 2020 Progress Report to Parliament, published on 25 June, that "Energy Performance Certificate ratings have had issues with inconsistent or inaccurate estimations and measurements, leading to the likelihood that homes that do not meet efficiency standards can be rented", what plans they have to strengthen the Energy Performance Certificate system.
tabling member printed	Baroness Bennett of Manor Castle
uin	HL6287
answer	answer is ministerial correction date of answer 14/07/2020 answer text <p>Since 1 April 2020, The Energy Efficiency (Private Rented Property) (England and wales) Regulations 2015 require that, subject to certain exemptions, all domestic private rented sector landlords in scope improve their properties to a minimum energy efficiency standard of Energy Performance Certificate (EPC) Band E.</p><p> </p><p>An EPC Call for Evidence ran from 26 July 2018 to 19 October 2018 and sought evidence on how EPCs performed against three attributes: quality, availability, and encouraging action to improve energy efficiency. The forthcoming Summary of Responses will outline the evidence received, including on effectiveness of EPCs. Alongside this, we will publish an EPC Action Plan to maximise the effectiveness of EPCs as a tool for the future.</p><p> </p><p>Additionally, BEIS is in the process of updating the Standard Assessment Procedure (SAP) – the methodology used to generate EPC scores. SAP is updated in line with the updates to Part L of the Building Regulations, usually every 3-5 years. The next version of SAP (SAP 10), was consulted on in 2017 and is due to come into force with the updated version of Part L of the Building Regulations.</p><p> </p><p>This SAP update together with the EPC Action Plan will help ensure home energy performance assessments are as accurate as possible.</p> answering member printed Lord Callanan question first answered 14/07/2020 15:26:27 answering member 4336 label Biography information for Lord Callanan
tabling member	4719 label Biography information for Baroness Bennett of Manor Castle

861304

registered interest
date	13/03/2018
answering body	Department for Business, Energy and Industrial Strategy
answering dept id	201
answering dept short name	Business, Energy and Industrial Strategy
answering dept sort name	Business, Energy and Industrial Strategy
hansard heading	Company Accounts
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty's Government, further to the Written Answer by Lord Henley on 5 March (HL5591), whether the statement on accounting standards by the Minister for Employment Relations and Consumer Affairs, published on 3 October 2013, was based on the Opinion of Mr Moore QC; if so, whether she knew the question or questions put to Counsel for that Opinion; and if applicable, why the content of that Opinion was taken into account in preparing that statement.
tabling member printed	Baroness Bowles of Berkhamsted
uin	HL6287
answer	answer is ministerial correction date of answer 27/03/2018 answer text <p>The statement made by the then Minister for Employment Relations and Consumer Affairs was based on internal advice including legal advice, which is the subject of legal professional privilege. The advice also included consideration of the draft opinion that was in preparation by Martin Moore QC because of its relevance to the statement.</p> answering member printed Lord Henley question first answered 27/03/2018 12:24:14 answering member 2616 label Biography information for Lord Henley
tabling member	4562 label Biography information for Baroness Bowles of Berkhamsted